9 results
8-K
EX-3.1
MRTX
Mirati Therapeutics Inc
23 Jan 24
Contingent Value Rights Agreement
8:48am
8-K
EX-3.2
MRTX
Mirati Therapeutics Inc
23 Jan 24
Contingent Value Rights Agreement
8:48am
DEFA14A
EX-3.1
MRTX
Mirati Therapeutics Inc
10 Oct 23
Additional proxy soliciting materials
7:35am
DEFA14A
EX-3.2
MRTX
Mirati Therapeutics Inc
10 Oct 23
Additional proxy soliciting materials
7:35am
8-K
EX-3.1
MRTX
Mirati Therapeutics Inc
10 Oct 23
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio with Acquisition of Mirati Therapeutics
7:33am
8-K
EX-3.2
qdx8s90r1f1ygklp360
10 Oct 23
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio with Acquisition of Mirati Therapeutics
7:33am
8-K
EX-3.1
3yl1 wcx70
16 Jun 16
Amendments to Articles of Incorporation or Bylaws
12:00am
10-12B
EX-3.1
h8kdr8nwsr
10 May 13
Registration of securities
12:00am
10-12B
EX-3.2
isv0cdqd avkra6pn236
10 May 13
Registration of securities
12:00am
- Prev
- 1
- Next